DealMultiValent Biotherapies, Inc., a Los Altos, CA-based prostate cancer drug conjugates developer, raised $27.4 million in a Series A fundraising round.
More on MedCity News →
SERIES A
06/19/2026
Moadna, a Syria-based clinic management and booking platform, raised...
Ajax Therapeutics, a New York and Cambridge, MA-based blood cancer drug...
OffPlan, an Atlanta-based membership-based primary care platform, raised...
Houdini Bio, a London-based gene therapy durability platform, raised £1.5...
Clair Health, a San Francisco-based women’s hormone-tracking wearable,...
Clario, a Menlo Park, CA-based enterprise data cleanup platform, raised $6...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
